NOT-NR-18-021: Notice to Extend the Expiration Date for PAR-18-158 "Applying Metabolomics to Drive Biomarker Discovery in Symptom Science (R21 Clinical Trial Optional)"

Notice to Extend the Expiration Date for PAR-18-158 "Applying Metabolomics to Drive Biomarker Discovery in Symptom Science (R21 Clinical Trial Optional)"

Notice Number: NOT-NR-18-021

Key Dates
Release Date:October 1, 2018

Related Announcements
PA-18-158

Issued by
National Institute of Nursing Research (NINR)

Purpose

The purpose of this Notice is to inform interested applicants that the expiration date for the Funding Opportunity Announcement (FOA) PAR-18-157 "Applying Metabolomics to Drive Biomarker Discovery in Symptom Science (R21 Clinical Trial Optional)" will be extended by one receipt cycle. This FOA now expires on May 8, 2019.

The FOA has been modified as follows:

Key Dates

Currently reads:

Expiration Date: January 8, 2019

Modified to read:

Expiration Date: May 8, 2019

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Martha Matocha, PhD
National Institute of Nursing Research (NINR)
Telephone: 301-594-2775
Email: matocham@mail.nih.gov